Mome-Air 120 Sava nasal spray for allergic rhinitis (12ml)

Dosage form 1 bottle box
Specifications Mometason Furoat

Ingredient

Thành phần cho 6ml

Composition information	Content
Mometason Furoat	3mg

Uses

indicated

Indications for adults and children 2 years and older to treat seasonal allergic rhinitis and allergic rhinitis all year round. up.

Dynamic pharmacokinetics

Mometason Furoat Monohydrate using nasal spray almost not detected in plasma in pediatric patients and adults despite using sensitive tests with a limited amount of less than 50 PCG/ml.

Before taking Mome-Air 120 Sava nasal spray for allergic rhinitis (12ml)

How to use

After the first bait pumps Mome-Air nasal spray pump (10 sprays, until you see the spray evenly), each time the press provides about 100 mg of Mometason Furoat, containing Mometason Furoat Monohydrate is equivalent to 50 microgram Mometason Furoat. If you do not use a spray for 14 days or more, bait must be pumped 2 spray, until you see the spray evenly, before using the next time. Shake the jar carefully before each use. The vial should be removed after spraying all the pumps on the label or within 2 months from the first use.

Dosage

Seasonal allergic rhinitis and allergic rhinitis all year round:

Adults and children aged 12 and older: The usual recommendation is 2 sprays on each side/day (50 micrograms/spray) (Total dose of 200 mcg). Seasonal allergies:

Adults and children aged 12 and older: The usual recommendation is 2 spray on each side/day (50 micrograms/spray) (total dose of 200 mcg). Season:

Adults and children aged 12 years and older: The usual recommendation is 2 spray on each side/day (50 micrograms/spray) (total dose of 200 mcg). Flowers.

Nose polyps:

Adults from 18 years of age: The usual recommendation dose of nasal polyps is 2 spray (50 mcg/spray) on each side daily - 2 times a day (total dose of 400 mcg). 2 sprays (50 mcg/spray) on each side of the nose daily-1 time (total dose of 200 mc) also effective in several patients.

What to do when overdose?

What to do when forgetting a dose?

Side Effects

The adverse reactions related to the treatment of allergic rhinitis are reported in clinical research in adult patients and adults are shown as follows (Table 1).

Table 1: Unwanted effects related to the treatment of allergic rhinitis of MOME nasal spray - Air

Very common (> 1/10); Common (> 1/100, 1/1000, Common

Nosebleeds, sore throat, nose, nose irritation, nose sores.Common

headache. The rate of other effects is equivalent to placebo.

In children with unwanted effects such as nosebleeds (6%), headache (3%), nose irritation (2%) and sneezing (2%) are the same as placebo.

In patients with nasal polyps, the rate of other undesirable effects is the same as placebo and similar in patients with allergic rhinitis treatment.

Unwanted effects related to the treatment of nasal polyps are reported ≥ 1% of patients in clinical research shown in the following table (Table 2).

Table 2: Unwanted effects related to the treatment of nasal polyps> 1% of Mome - Air

Very common (> 1/10); Common (> 1/100, 1/1000, 1/10,000,

(200 mcg 1 time/day)

(200 mcg 2 times/day)

Lower respiratory infections

nosebleeds

Common Common

Not common

Very common

throat irritation

- Common

Headache

Common Common

Rarely have instant allergies such as bronchospasm, shortness of breath can occur after spraying Mometason Furoat Monohydrate into the nose. Very rarely have sensitivity and angioedema.

The taste and smell disorder is reported very rare.

Notice the doctor unwanted effects when taking the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

sensitive to any ingredients of the drug.

Mome-Air nasal spray is not used when there are localized infections in the nasal mucosa, fungal infection, viral infection and nasal ulcer.

Because of the effect of inhibiting wound healing of corticosteroids, patients who have just surgery nose or nasal trauma are not used with corticosteroids until healing.

Be cautious when using

Mome-Air nasal spray must be used carefully for patients with non-functional respiratory tuberculosis or active, or systemic viruses, bacteria, fungi that have not been treated or herpes simplex in the eye.

After 12 months of treatment with Mome-Air nasal spray has no evidence of nasal atrophy, as well as, Mometason Furoat tends to restore the nasal mucosa close to the normal learning model. As with any long-term treatment, patients who use Mome-Air nasal spray for a few months or longer must be periodically tested for possible changes in the nasal mucosa. If the fungal infection appears in the nose or throat, the Mome-Air nasal spray is discontinued or may require appropriate treatment. Persistent nasopharyngeal irritation may be an indication to stop the Mome-AR nasal spray.

Although Mome-Air will control nasal symptoms in most patients, and add appropriate therapies that can reduce other symptoms, especially eye symptoms.

There is no evidence of the hypothalamus-axis of Yen-Theme (HPA) after prolonged treatment with Mome-Air nasal spray. However, patients transferred from long-term use of systemic corticosteroids to Mome-Air nasal sprays that need to be carefully monitored. Stop using whole corticosteroids in these patients can lead to adrenal insufficiency for a few months until the function of the HPA axis recovers. If these patients show signs and symptoms of adrenal insufficiency, the use of corticosteroids must be repeated and other treatments and appropriate evaluation must be conducted.

While transferring from body corticosteroids to Mome-Air nasal spray, some patients may have symptoms of stopping the use of systemic corticosteroids (either joint and or muscle, fatigue and begins to be weak), despite the reduction of nasal symptoms and will need encouragement to continue the treatment of Mome-Air nasal spray. Such medication may also be revealing allergens that exists in advance such as allergic conjunctivitis and Eczema, which has been previously inhibited by systemic therapy.

The safety and effectiveness of Mome-Air nasal sprays have not been studied for use in one-sided polyp treatment, polyps are associated with cystic fibrosis or polyp completely obstructing the nasal cavity. Polyps are rare or irregular, especially ulcers or bleeding should be considered more carefully. Patients who use corticosteroids that have been inhibited immunosuppressants must be warned about the risk of exposure to bacterial infections (for example, chickenpox, measles) and the importance of a physician's consultation if there are such contacts.

After using sprayed corticosteroids into the nose, the cases of separate puncture of the nasal septum or increased intraocular pressure have been reported very rare.

Safety and effectiveness of Mome-Air nasal spray for nasal polyps in children and teenagers under 18 years of age have not been studied.

The systemic effect of corticosteroids nasal spray is possible, especially at high doses for a long time. Development retardation has been reported in children with corticosteroid treatment for the nasal doses at the allowed dose.

Recommendations for the height of children with long -lasting corticosteroid nasal sprays must be monitored regularly. If the development is slowed down, the therapy should be reviewed with the goal of reducing the corticosteroid dose using the nose, if possible, the lowest dose has the effect of controlling symptoms should be maintained.

The effect of the drug on driving and operating machinery

No report.

Use drugs for women during pregnancy and nursing mothers

There are no studies that are well -controlled or fully controlled in pregnant women. After nasal spraying the maximum clinical recommendations for patients, the concentration of mometason in plasma is not measured, so the exposure of the fetus with the drug is thought to be negligible and the ability to be toxicity with reproduction is very low.

As well as other nose corticosteroid preparations, Mome-Air nasal spray should only be used for pregnant women, nursing mothers or women at reproductive age when benefits may be greater than the potential risk for mothers, fetuses and young children. Children with mothers use corticosteroids during pregnancy must be carefully monitored about adrenal insufficiency.

Interactive drug

Mome-Air nasal spray has been used simultaneously with loratadin or its main metabolites in plasma. Mometason Furoat concentration in plasma is not detected. Combination treatment is well tolerated.

Storage

Store in a cool dry place, avoid light, store at a temperature not exceeding 30 ° C.

Keep the drug out of reach of children.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.